期刊文献+

癌性贫血与血清促红细胞生成素关系研究 被引量:1

Study of the relationship between serum erythropoietin and carcinous anemia
下载PDF
导出
摘要 目的:分析癌性贫血患者血清促红细胞生成素(Epo)的水平及其与血红蛋白(Hb)水平的关系。方法:对53例癌性贫血、71例癌症无贫血和20例正常对照的血清用ELISA法检测Epo值。结果:(1)癌性贫血组、癌症无贫血组、对照组的血清Epo分别为:(63.08±104.1)mu/ml、(12.48±9.96)mu/ml和(8.10±4.97)mu/ml。癌性贫血组与癌症无贫血组及与对照组相比较有统计学意义(分别为P<0.001和P<0.05)。癌症无贫血组与对照组无统计学意义(P>0.05)。(2)癌性贫血患者的Epo水平与Hb水平存在负相关(r=-0.693,P<0.001)。结论:癌性贫血患者的Epo值高于癌症无贫血患者和正常人,并与Hb值呈负相关。 Objective :To explore the chnical significance of serum erythropoietin(EPO) level and the relationship between EPO level and Haemoglobin (Hb) level in patients with carcinous anemia for improving the life quality in cancer patients. Methods:The serum EPO level was detected in 38 cases of carcinous anemia, 66 cases of cancer patients without anemia and 20 cases of normal controls.Results: The mean expressing level of the serum EPO in carcinous anemia group,cancer patients without anemia group and controls was (64.0± 97.0)mu/rnl, (12.6±11.4)mu/ml, (8.1±5.0)mu/ml respectively. The mean expressing level of the serum EPO in careinous anemia group was significantly higher than that in cancer patients without anemia group and control group.There was no significant difference in the mean expressing level of the serum EPO between cancer patients without anemia group and control group.A negative correlation was found between the levels of EPO and Hb in carcinous anemia patients.Conclusion:The serum EPO level in patients with carcinous anemia was responsively increased.
出处 《现代医药卫生》 2007年第22期3328-3329,共2页 Journal of Modern Medicine & Health
关键词 癌性贫血 促红细胞生成素 血红蛋白 Carenous aneimia Serum erythropoietin Haemoglobin
  • 相关文献

参考文献11

  • 1Jelkmarm W.Molecular biology of erythropoietin[J].Intem Med, 2004, 43(8) :649.
  • 2Heinz L, Simon B, Peter BL, et al.The European Cancer Anaemia Survey(ECSA) : A large,multinational,prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients[J]. Ear J Cancer, 2004,40(15):2293.
  • 3Gropman JE, Itri LM.Chemotherapy-induced anaemia in adult:incidence and treatment[J].J Natl Cancer Inst, 1999,91:1616.
  • 4Littlewood TJ,Bajetta E,Nortier JW,et al. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy:results of a randomized,double-blind placebo-controlled trail[J].J Clin Oncol,2002,20(2):601.
  • 5庞丹梅,卫光宇,李精明,陈泽程,唐溢聪,梁剑苗,招丽蓉.内源性红细胞生成素水平与癌性贫血关系的临床分析[J].肿瘤防治杂志,2005,12(17):1304-1306. 被引量:9
  • 6顾琳萍,陆舜.贫血与肺癌[J].临床肿瘤学杂志,2007,12(6):401-406. 被引量:8
  • 7Arslan M,Evrensel T,Kurt E ,et al.Comparlson of the serum erythropoietin levels in chemothempy-nalve and cisplatin-treated cancer patients[J].Neoplasma,2005,52(1):43.
  • 8Kostova G, Siljanovski N.Erythropoietin production in patients with malignant lymphoma[J].Prilozi, 2005,26(2) : 157.
  • 9Braczkowski R, Romanawsky W, Danikiewicz A, et al. Decrease of erythropoietin level by human recombinant tumour necrosis factor alpha (hrec TNFalpha) in patients with advanced cancer[J].J Biol Regul Homeost Agents,2001,15(4) :366.
  • 10La Ferla K,Reimann C ,Jelkmann W,et al.Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB[J].FASEB J,2002,16(13):1811.

二级参考文献59

  • 1李美红,缪泽鸿,丁健.靶向肿瘤缺氧[J].中国癌症杂志,2004,14(5):486-489. 被引量:6
  • 2Reed W R, Hussey D H, DeGowing R L, et al. Implications of the anemia of chronic disorders in patients anticipating radiotherapy[J]. AmJ MedSci, 1994, 308(1): 9-15.
  • 3Quirt I, Robeson C, Lau C Y, et al. Epoetin alfa therapy in creases hemoglobin levels and improves quality of life in patients with cancer related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy[J]. JClin Oncol, 2001, 19(21) :4126-4134.
  • 4Petersdorf S H, Dale D C. The biology and clinical applications of erythropoietin and the colony-stimulating factors[J]. Adv Intern Med, 1995,40: 395 - 428.
  • 5Spivak J L. Recombinant human erythropoietin and anemia of cancer[J]. Blood,1994,84(4) :997-1004.
  • 6Ludwig H, Fritz E, Leitgeb C, et al. Prediction of response to erythropoietin treatment in chronic anemia of cancer[J]. Blood 1994, 84(4): 1056 1063.
  • 7Ludwig H, Fritz E. Anemia in cancer patients[J]. Semin On col,1998,25(Suppl 7) :2-6.
  • 8Littlewood T J, Bajetta E, Nortier J W R, et al. Effect of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non platinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial [J]. J Clin Oncol, 2001, 19(11):2865-2874.
  • 9Means R T, Krants S B. Inhibition of human erythroid colonyforming units by gamma interferon can be corrected by recombinant human erythropoietin [J]. Blood, 1991, 78(10): 2564-2567.
  • 10Noble J.Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer:A systematic review and practice guideline[J].Journal of Thoracic Oncology,2006,1(9):1042-1058.

共引文献13

同被引文献9

  • 1陈衍,刘文超,程婕.癌性贫血的最新临床研究进展[J].现代肿瘤医学,2008,16(11):1995-1998. 被引量:13
  • 2庞丹梅,卫光宇,李精明,陈泽程,唐溢聪,梁剑苗,招丽蓉.内源性红细胞生成素水平与癌性贫血关系的临床分析[J].肿瘤防治杂志,2005,12(17):1304-1306. 被引量:9
  • 3Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 2004, 40:2293-2306.
  • 4Hockel M, Vaupel P. Tumor hypoxia: definitions and current clinieal, biologic, and molecular aspects. J Natl Cancer lnst, 2001,93:266- 276.
  • 5Ferrario E, Ferrari L, Bidoli P, et al. Treatment of cancer-related anemia with epoetin alfa:a review. Cancer Treat Rev, 2004, 30: 563-575.
  • 6Harrison LB, Shasha D, White C, et al. Radiotherapy-associated anemia: the scope of the problem. Oncologist, 2000, 5 Suppl 2: 1-7.
  • 7Okazaki T, Ebihara S, Asada M, et al. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor- bearing mice by enhancing angiogenesis. Neoplasia, 2008, 10: 932-939.
  • 8Leyland-Jones B, BEST Investigators and Study Group. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol, 2003, 4:459-460.
  • 9Henke M, Laszig R, Rtibe C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet, 2003, 362 : 1255-1260.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部